BD Medical-Pharmaceutical Systems to hold Technovation Season 9

The event will further Becton Dickinson’s efforts to strengthen partnerships with pharmaceutical companies and bring relevant solutions to create a positive impact on the lives of patients

0
60

Mumbai: BD Medical-Pharmaceutical Systems is all set to organize its annual flagship event ‘Technovation’ Season 9 on the emerging trends and innovative technologies for the pharmaceutical industry. With this year’s theme ‘Together Towards a Healthier Tomorrow’, Technovation will be conducted across three cities – Mumbai (August 20), Ahmedabad (August 21) and Hyderabad (August 22). The programme will witness participation from leading pharmaceutical and biotechnology companies across these cities.

The event will further BD’s efforts to strengthen partnerships with pharmaceutical companies and bring relevant solutions to create a positive impact on the lives of patients. This edition will bring together global experts to talk about innovation in packaging for complex biologics through evolving self-administration devices, technical services, evolving quality landscape to support customer needs and regulatory services and support from BD. It will also focus on the regulatory aspects including the discussions on FDA and European regulations.

Commenting on the upcoming event, Pavan Mocherla, Managing Director-BD India & South Asia said, “With Technovation, we aim to create a platform to bring key pharma stakeholders together for knowledge sharing and discussions to advance patient outcomes by ensuring compliance, ease of use and adherence to treatment. This season will have focussed discussions on self-administered devices and the impact of such technologies on the lives of patients suffering from chronic diseases. Such initiatives not only help us engage closely with our customers but also help us equip each other with the best know-how to create a healthier tomorrow.”

The upcoming event will also focus on the regulatory aspects and will include the discussions on the FDA and European regulations and how technical and quality services play a critical role in delivering a positive impact on patient outcomes.